Last update 13 Sep 2025

ATA-2431

Overview

Basic Info

Drug Type
Universal CAR-T
Synonyms
ATA 2431, AVA-014
Target
CD19 x CD20
Action
inhibitors, stimulants
Mechanism
CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), CD20 stimulants(B-lymphocyte antigen CD20 stimulants), Immunologic cytotoxicity
Therapeutic Areas
NeoplasmsHemic and Lymphatic Diseases
Active Indication-
Inactive Indication
Hematologic Neoplasms
Originator Organization
H. Lee Moffitt Cancer Center & Research Institute, Inc.H. Lee Moffitt Cancer Center & Research Institute, Inc.
Active Organization-
Inactive Organization
H. Lee Moffitt Cancer Center & Research Institute, Inc.H. Lee Moffitt Cancer Center & Research Institute, Inc.Atara Biotherapeutics, Inc.Atara Biotherapeutics, Inc.
License Organization
Atara Biotherapeutics, Inc.Atara Biotherapeutics, Inc.H. Lee Moffitt Cancer Center & Research Institute, Inc.H. Lee Moffitt Cancer Center & Research Institute, Inc.
Drug Highest PhaseDiscontinuedPreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with ATA-2431
Login to view more data
100 Translational Medicine associated with ATA-2431
Login to view more data
100 Patents (Medical) associated with ATA-2431
Login to view more data
100 Deals associated with ATA-2431
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hematologic NeoplasmsPreclinical
United States
Atara Biotherapeutics, Inc.Atara Biotherapeutics, Inc.
06 Sep 2018
Hematologic NeoplasmsPreclinical
United States
H. Lee Moffitt Cancer Center & Research Institute, Inc.H. Lee Moffitt Cancer Center & Research Institute, Inc.
06 Sep 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free